BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28681618)

  • 21. Phoyunnanin E Induces Apoptosis of Non-small Cell Lung Cancer Cells
    Phiboonchaiyanan PP; Petpiroon N; Sritularak B; Chanvorachote P
    Anticancer Res; 2018 Nov; 38(11):6281-6290. PubMed ID: 30396948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of LS174T colorectal cancer stem-like cells with n-3 PUFAs induces growth suppression through inhibition of survivin expression and induction of caspase-3 activation.
    Sam MR; Ahangar P; Nejati V; Habibian R
    Cell Oncol (Dordr); 2016 Feb; 39(1):69-77. PubMed ID: 26671842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells.
    Zhou M; Gu L; Li F; Zhu Y; Woods WG; Findley HW
    J Pharmacol Exp Ther; 2002 Oct; 303(1):124-31. PubMed ID: 12235242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytotoxic proteins combined with prodigiosin obtained from Serratia marcescens have both broad and selective cytotoxic activity on tumor cells.
    Abrahantes-Pérez MC; Reyes-González J; Véliz Ríos G; Bequet-Romero M; Gómez Riera R; Anais Gasmury C; Huerta V; González LJ; Canino C; Garcia J; Váldez J; Reyes B; Váldes R; Martínez E
    J Chemother; 2006 Apr; 18(2):172-81. PubMed ID: 16736886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prodigiosin/PU-H71 as a novel potential combined therapy for triple negative breast cancer (TNBC): preclinical insights.
    Anwar MM; Shalaby M; Embaby AM; Saeed H; Agwa MM; Hussein A
    Sci Rep; 2020 Sep; 10(1):14706. PubMed ID: 32895397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prodigiosin, the red pigment of Serratia marcescens, shows cytotoxic effects and apoptosis induction in HT-29 and T47D cancer cell lines.
    Dalili D; Fouladdel Sh; Rastkari N; Samadi N; Ahmadkhaniha R; Ardavan A; Azizi E
    Nat Prod Res; 2012; 26(22):2078-83. PubMed ID: 21985476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survivin modulation in the antimelanoma activity of prodiginines.
    Branco PC; Pontes CA; Rezende-Teixeira P; Amengual-Rigo P; Alves-Fernandes DK; Maria-Engler SS; da Silva AB; Pessoa ODL; Jimenez PC; Mollasalehi N; Chapman E; Guallar V; Machado-Neto JA; Costa-Lotufo LV
    Eur J Pharmacol; 2020 Dec; 888():173465. PubMed ID: 32814079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KLF5 Interacts with p53 in regulating survivin expression in acute lymphoblastic leukemia.
    Zhu N; Gu L; Findley HW; Chen C; Dong JT; Yang L; Zhou M
    J Biol Chem; 2006 May; 281(21):14711-8. PubMed ID: 16595680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of ABT-737 and resveratrol enhances DNA damage and apoptosis in human T-cell acute lymphoblastic leukemia MOLT-4 cells.
    Opydo-Chanek M; Rak A; Cierniak A; Mazur L
    Toxicol In Vitro; 2017 Aug; 42():38-46. PubMed ID: 28366708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of survivin and p53 modulates honokiol-induced apoptosis in colorectal cancer cells.
    Lai YJ; Lin CI; Wang CL; Chao JI
    J Cell Biochem; 2014 Nov; 115(11):1888-99. PubMed ID: 24905183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topotecan triggers apoptosis in p53-deficient cells by forcing degradation of XIAP and survivin thereby activating caspase-3-mediated Bid cleavage.
    Tomicic MT; Christmann M; Kaina B
    J Pharmacol Exp Ther; 2010 Jan; 332(1):316-25. PubMed ID: 19812371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiproliferative potential of a novel parthenin analog P16 as evident by apoptosis accompanied by down-regulation of PI3K/AKT and ERK pathways in human acute lymphoblastic leukemia MOLT-4 cells.
    Goswami A; Shah BA; Kumar A; Rizvi MA; Kumar S; Bhushan S; Malik FA; Batra N; Joshi A; Singh J
    Chem Biol Interact; 2014 Oct; 222():60-7. PubMed ID: 25196075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The anticancer agent prodigiosin induces p21WAF1/CIP1 expression via transforming growth factor-beta receptor pathway.
    Soto-Cerrato V; Viñals F; Lambert JR; Pérez-Tomás R
    Biochem Pharmacol; 2007 Nov; 74(9):1340-9. PubMed ID: 17765876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of tachykinin NK
    Bayati S; Bashash D; Ahmadian S; Safaroghli-Azar A; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
    Eur J Pharmacol; 2016 Nov; 791():274-283. PubMed ID: 27609608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prodigiosin-induced apoptosis in human colon cancer cells.
    Montaner B; Pérez-Tomás R
    Life Sci; 2001 Mar; 68(17):2025-36. PubMed ID: 11388704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of undifferentiated colorectal cancer cells with fish-oil derived docosahexaenoic acid triggers caspase-3 activation and apoptosis.
    Ahangar P; Sam MR; Nejati V; Habibian R
    J Cancer Res Ther; 2016; 12(2):798-804. PubMed ID: 27461654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prodigiosin induces cell death and morphological changes indicative of apoptosis in gastric cancer cell line HGT-1.
    Díaz-Ruiz C; Montaner B; Pérez-Tomás R
    Histol Histopathol; 2001 Apr; 16(2):415-21. PubMed ID: 11332697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The kinesin Eg5 inhibitor K858 induces apoptosis but also survivin-related chemoresistance in breast cancer cells.
    De Iuliis F; Taglieri L; Salerno G; Giuffrida A; Milana B; Giantulli S; Carradori S; Silvestri I; Scarpa S
    Invest New Drugs; 2016 Aug; 34(4):399-406. PubMed ID: 26994617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tetramethylpyrazine inhibits the proliferation of acute lymphocytic leukemia cell lines via decrease in GSK-3β.
    Wang XJ; Xu YH; Yang GC; Chen HX; Zhang P
    Oncol Rep; 2015 May; 33(5):2368-74. PubMed ID: 25812605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prodigiosin induces apoptosis of B and T cells from B-cell chronic lymphocytic leukemia.
    Campàs C; Dalmau M; Montaner B; Barragán M; Bellosillo B; Colomer D; Pons G; Pérez-Tomás R; Gil J
    Leukemia; 2003 Apr; 17(4):746-50. PubMed ID: 12682632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.